Project Details
Description
An interventional, Phase 3 extension study to investigate, long-term safety and tolerability of tolebrutinib in participants with relapsing multiple sclerosis, primary
progressive multiple sclerosis, or non-relapsing secondary progressive multiple sclerosis
progressive multiple sclerosis, or non-relapsing secondary progressive multiple sclerosis
| Short title | LTS17043 |
|---|---|
| Status | Active |
| Effective start/end date | 01.06.2024 → 01.01.2029 |
Fields of science
- 302052 Neurology
- 305 Other Human Medicine, Health Sciences
- 302 Clinical Medicine
- 303 Health Sciences
- 301 Medical-Theoretical Sciences, Pharmacy